Stada Buys 15 Over-the-Counter Products from GSK for $325 Million

Frankfurt, Germany-based generic drugmaker Stada is buying 15 consumer healthcare products from UK’s GlaxoSmithKline. According to two sources familiar with the deal, Stada is paying more than $325 million.